Leike Li

Harbin Institute of Technology

Papers

1

Total Citations

10

H-Index

1

About

Leike Li is a pioneering researcher at the intersection of biomedical engineering and nanotechnology, with a primary focus on intelligent drug delivery systems and cancer therapeutics. Their most notable contribution involves the development of magnetic-driven hydrogel microrobots, which represent a paradigm shift from conventional passive drug delivery to active, navigable therapeutic platforms. In their highly cited 2024 work, Li introduced a synthetic lethality strategy for osteosarcoma chemotherapy, demonstrating how these microrobots can be precisely guided to tumor sites, significantly enhancing treatment efficacy while minimizing systemic toxicity. This breakthrough has already garnered 10 citations, reflecting its immediate impact on the field. Li’s research elegantly bridges materials science, robotics, and oncology, offering a transformative approach to targeted cancer therapy. Their work not only advances the fundamental understanding of micro-robot navigation in biological environments but also provides a tangible pathway toward clinical applications in hard-to-treat cancers. For students and researchers, Li exemplifies how interdisciplinary innovation can address critical challenges in precision medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Magnetic-driven hydrogel microrobots for promoting osteosarcoma chemo-therapy with synthetic lethality strategy
10 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Harbin Institute of Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago